A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia

NCT02944383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hypertriglyceridemia
Mixed Dyslipidaemia

Interventions

DRUG: Gemcabene
DRUG: Placebo

Sponsor

NeuroBo Pharmaceuticals Inc.